NEW YORK — Fenwick announced today that Roger Cohen has joined the firm as a partner in its New York office and healthcare regulatory practice.
“For our life sciences and technology clients, regulatory considerations are central to the work we do,” said Fenwick Chair Richard Dickson. “Roger strengthens the comprehensive support we provide as those clients navigate an ever-evolving healthcare landscape that requires counsel with precision and judgment. We’re excited to welcome him to Fenwick.”
Working closely with the firm’s corporate, intellectual property, and litigation teams, Cohen will advise healthcare services, life sciences, healthtech, and investor clients throughout their lifecycles. His practice spans healthcare transactions, regulatory and strategic counseling, and emerging areas of digital health and artificial intelligence.
“Roger knows how to translate healthcare regulatory requirements into practical guidance for companies and investors,” said Corporate Chair Alan Smith. “Whether a client is structuring a transaction, developing a new business model, or responding to government scrutiny, his experience will help our teams anticipate challenges and address them earlier.”
In addition to his counseling and transactional work, Cohen also has a strong record representing clients in government investigations and healthcare litigation, with a reputation for resolving disputes without enforcement action, and dismissals in significant healthcare fraud cases before trial.
“The most consequential decisions healthcare and life sciences companies make rarely fall within a single area of law,” Cohen said. “Fenwick brings together deep technology and life sciences experience with a collaborative approach to client service. I’m excited to join a team that understands the broader business context and helps clients move forward with confidence.”
Cohen’s arrival builds on Fenwick’s growth in New York and other key markets. Earlier this year, the firm welcomed patent litigation partner Krishnan (KP) Padmanabhan and corporate partner Alexander Rea in New York, and patent litigation partner Scott Border and congressional investigations counsel Anna Uhls in Washington, D.C.
About Fenwick’s Healthcare Regulatory Practice
Fenwick’s healthcare regulatory practice advises technology, life sciences and healthcare companies on the legal requirements governing healthcare delivery and innovation. The practice works closely with the firm’s corporate, litigation and privacy teams to address regulatory issues arising from transactions, business operations and government scrutiny. Its experience spans healthcare compliance, digital health, reimbursement, fraud and abuse, and investigations. By integrating regulatory counsel with the firm’s broader technology and life sciences capabilities, the team helps clients manage legal risk while advancing their business objectives.
About Fenwick
Fenwick is a leading law firm, purpose-built to guide visionary tech and life sciences companies and their investors through every stage of growth, from startups securing their first round of funding to leading publicly traded global enterprises. As one of Silicon Valley’s original legal practices, today we have over 600 lawyers, patent agents, engineers, and scientists serving clients all over the world. Our work has earned consistent recognition from Chambers and Law360, including first-tier Chambers rankings and Law360 Practice Group of the Year honors in technology and life sciences. Visit www.fenwick.com to learn more.
